| Literature DB >> 35329361 |
Maryam Molaeikhaletabadi1, Reza Bagheri2, Mohammad Hemmatinafar1, Javad Nemati1, Alexei Wong3, Michael Nordvall3, Maryam Namazifard4, Katsuhiko Suzuki5.
Abstract
This study investigated the short-term effects of low-fat chocolate milk (LFCM) consumption on delayed onset muscle soreness (DOMS) and performance in female badminton players. Seven female badminton players (23 ± 1 years; height: 163.8 ± 4.1 cm; body mass: 58.7 ± 0.9 kg) were randomly assigned to 1 week of LFCM (500 mL) or placebo (water, 500 mL) consumption in a crossover design. Participants consumed LFCM or water immediately after each training session during the 1-week intervention. Performance variables (aerobic power, anaerobic power, agility, explosive power, and maximum handgrip strength) were assessed at two separate time points: pre and post-intervention (after 1 week). In addition, the Visual Analogue Scale (VAS) was used to assess DOMS before, immediately after, and at 24 and 48 h after each training session. There were significant time effects for aerobic power, upper body explosive power, minimum anaerobic power, and time to exhaustion (TTE), which significantly increased after LFCM consumption (p < 0.05). Moreover, relative and maximum lower body power significantly (p < 0.05) increased, while rating of perceived exertion (RPE) as well as DOMS in lower extremity muscles immediately after exercise significantly decreased after LFCM consumption compared to placebo (p < 0.05). There were no significant changes in maximum anaerobic power, agility, and maximum handgrip strength (p > 0.05). LFCM, as a post-exercise beverage, may help speed recovery in female badminton players leading to increased aerobic, anaerobic, and strength performance indices, increased TTE, and decreased muscle soreness and RPE.Entities:
Keywords: DOMS; aerobic performance; anaerobic performance; badminton players; carbohydrate–protein beverage; chocolate milk; post-exercise recovery
Mesh:
Substances:
Year: 2022 PMID: 35329361 PMCID: PMC8954613 DOI: 10.3390/ijerph19063677
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Schematic study design.
Energy and nutrient composition of LFCM (500 mL).
| Energy (Kcal) | 370 |
| Fat (g) | 7.5 |
| Protein (g) | 16 |
| Carbohydrate (g) | 59.5 |
| Calcium (mg) | 600 |
| Phosphorus (mg) | 500 |
Participant characteristics.
| Age (y) | 23.14 ± 1.5 years |
| Height (cm) | 163.8 ± 4.1 cm |
| Body mass (kg) | 58.7 ± 0.9 kg |
| Body mass index (kg/m2) | 21.9 ± 3.5 kg/m2 |
Subjective measurements of YOYO intermittent test (Time To Exhaustion (TTE), aerobic power (VO2max (mL/min/kg))), RAST test (maximum anaerobic power (Watt), minimum anaerobic power (Watt), average anaerobic power (Watt)), SEMO Test (Agility (sec)), medicine ball throw test (explosive power of the upper body (meter)), handgrip dynamometer (max hand strength (kg)), Vertical Jump Test (relative explosive power of the lower body (Watt), maximum explosive power lower body (Watt)) on baseline, post-test placebo and post-test LFCM. Values are mean ± SD (p < 0.05) (* = Significantly different (p < 0.05) from baseline, # = significantly different (p < 0.05) from post-test placebo).
| TTE | Aerobic Power | Max Anaerobic Power | Min Anaerobic Power | Ave Anaerobic Power | Agility | Explo Power Upper Body | Max Hand Strength | Rel Explo Power Lower Body | Max Explo Power Lower Body | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-test | 262.8 ± 39 | 38.6 ± 0.32 | 266.1 ± 56.4 | 134.5 ± 28.4 | 195 ± 43.9 | 14.8 ± 1.1 | 4.4 ± 0.5 | 22.8 ± 4.7 | 1089.6 ± 258.6 | 2402.1 ± 508.6 | |
| Post-test | 301.4 ±38.4 | 38.9 ± 0.32 | 234.1 ± 37.4 | 141.4 ± 32.6 | 184.01± 30.3 | 14.3 ± 0.35 | 5 ± 0.36 | 24 ± 4.8 | 1196 ± 264.7 * | 2593 ± 514 * | |
| Post-test | 325.7 ± 67 * | 39.1 ± 0.56 * | 252.5 ± 64.6 | 159 ± 35.5 * | 200.1 ± 41.1 | 14.2 ± 0.38 | 5.1 ± 0.31 * | 25.5 ± 3.9 | 1265.7 ± 304.6 *# | 2716.5 ± 583.8 *# | |
Figure 2Subjective measurements of maximum and relative explosive power of lower extremity muscles on post-test–placebo and post-test–LFCM. Values are mean (* = Significantly different (p < 0.05) from maximum explosive power week placebo, ** = Significantly different (p < 0.05) from relative explosive power week placebo, † = Significantly different (p < 0.05) from relative explosive power baseline, ‡ = Significantly different (p < 0.05) from maximum explosive power baseline).
Figure 3Subjective measurements of delayed onset soreness of lower extremity muscles before exercise, immediately post-exercise, 24 h post-exercise, and 48 h post-exercise for each training session of week placebo and week chocolate milk. Values are mean ± SD (p < 0.05) (* = Significantly different (p < 0.05) from week placebo).
Subjective measurements of RPE and delayed onset soreness of upper body and lower body in the placebo and chocolate milk interventions. Values are mean ± SD (p < 0.05) (* = Significantly different (p < 0.05) from week placebo).
| RPE | DOMS (Upper Body) | DOMS (Lower Body) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before Exercise | IP | Post 24 h | Post 48 h | Before Exercise | IP | Post 24 h | Post 48 h | |||
| Week Placebo | 11.8 ± 0.69 | 3.5 ± 0.77 | 2.18 ± 0.75 | 0 | 0 | 8.71 ± 1.6 | 15.28 ± 3.63 | 13.57 ± 3.62 | 11.85 ± 2.85 | |
| Week LFCM | 10.5 ± 0.78 * | 0 | 6.42 ± 1.8 | 0 | 0 | 7.14 ± 2.8 | 5.71 ± 1.52 * | 10.42 ± 2.45 | 1.42 ± 0.74 | |
IP: Immediate post-exercise.